Mary L. Johnson
Director of Clinical Research
Pharmaceuticals
CeQur
Switzerland
Biography
Director of Clinical Research at the International Diabetes Center, where testing has occurred on almost every new diabetes medication and device on the market today. She has developed protocols and has served as project director on numerous research trials and co-authored articles and abstracts in the specialty areas of hypertension, cardiology, nephrology and diabetes. Ms. Johnson is a member of the steering committee and a Project Leader for the NIH multi-center study entitled ACCORD, "Action to Control Cardiovascular Risk in Diabetes." She has also had industry experience as a clinical research monitor, ensuring accuracy of data reported to sponsoring companies and adherence to FDA regulations. Ms. Johnson is a member of the American Diabetes Association and speaks on diabetes topics in the local, state and national arena.
Research Interest
diabetes
